Par Drugs and Chemicals Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 229.33 million compared to INR 169.16 million a year ago. Revenue was INR 229.7 million compared to INR 169.67 million a year ago. Net income was INR 18.68 million compared to INR 21.15 million a year ago. Basic earnings per share from continuing operations was INR 1.52 compared to INR 1.72 a year ago. Diluted earnings per share from continuing operations was INR 1.52 compared to INR 1.72 a year ago.
For the nine months, sales was INR 712.57 million compared to INR 529.94 million a year ago. Revenue was INR 714.64 million compared to INR 531.11 million a year ago. Net income was INR 78.87 million compared to INR 67.91 million a year ago. Basic earnings per share from continuing operations was INR 6.41 compared to INR 5.52 a year ago. Diluted earnings per share from continuing operations was INR 6.41 compared to INR 5.52 a year ago.